MedPath

CoolSculpting and EMS for the Abdomen

Not Applicable
Completed
Conditions
Body Fat Disorder
Interventions
Device: The ZELTIQ System
Registration Number
NCT03738891
Lead Sponsor
Zeltiq Aesthetics
Brief Summary

Evaluate the use of Electromagnetic Muscle Stimulation as an adjunctive treatment to CoolSculpting.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Fat ReductionThe ZELTIQ SystemThe treatments are designed to see if the fat can be reduced in the abdomen.
Primary Outcome Measures
NameTimeMethod
Number of Unanticipated Adverse Device Effects (UADE)Enrollment through the final 12-week follow-up visit.

The number of UADEs occurring during the study will be tabulated.

Number of Participants With Global Aesthetic Improvement Per Independent Physician Review of Photographs Based on Investigator Global Aesthetic Improvement Scale (GAIS-Independent)Baseline photos will be compared to images collected at the final 12-week post-treatment follow-up visit.

Comparison of pre-treatment- and 12-week post-final treatment photographs by independent physician reviewer. The reviewer was blinded to the method of treatment and study cohort; baseline and 12-week post-treatment photos were not blinded. After Sponsor training, the reviewer entered assessments according to the Global Aesthetic Improvement Scale (GAIS). The GAIS had outcome choices of "very much improved", "much improved", "improved", "no change", "worse", "much worse", or "very much worse", with "very much improved" representing the most aesthetic improvement. Reported here is the sum of participants who were assessed as improved ("Very Much Improved," "Much Improved", and "Improved").

Secondary Outcome Measures
NameTimeMethod
Percentage of Participants With Global Aesthetic Improvement Scale (S-GAIS) Reporting ImprovementFinal post-treatment 12-week follow-up visit

Subjects completed a graded 7-point GAIS at 12-week post-final treatment follow-up. The scale consists of the following response options: 3 = Very much improved; 2 = Much improved; 1 = Improved; 0 = No change; -1 = Worse; -2 = Much worse; -3 = Very much worse. Results were tabulated across the three treatment cohorts. Results were calculated in the percentage of the subjects reporting improvement.

Change in Pre-treatment and Post-treatment Abdominal CircumferenceBaseline and final 12-week follow-up visit.

Abdominal circumference as measured by 3-Dimensional imaging prior to treatment (baseline) is compared to images collected at the final 12-week post-treatment follow-up visit. Measurements were captured at 3 points including the upper, middle and lower abdomen. All measurements were averaged per subject at the baseline and 12-week visit time points to obtain circumference values. Results for each cohort are shown in millimeters of circumference reduction.

Trial Locations

Locations (4)

Innovation Research Center

🇺🇸

Pleasanton, California, United States

Marina Plastic Surgery

🇺🇸

Marina Del Rey, California, United States

Laser & Skin Surgery Center of Northern California

🇺🇸

Sacramento, California, United States

Aesthetic Solutions, P.A.

🇺🇸

Chapel Hill, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath